Metabolic effects of Tofogliflozin are efficiently enhanced with appropriate dietary carbohydrate ratio and are distinct from carbohydrate restriction-Reference-Cited by-同舟云学术

Metabolic effects of Tofogliflozin are efficiently enhanced with appropriate dietary carbohydrate ratio and are distinct from carbohydrate restriction

Published:2018-03 Issue:5 Volume:6 Page:e13642
ISSN:2051-817X
Container-title:Physiological Reports
language:en
Short-container-title:Physiol Rep

Author:

Ito Shiori¹,Hosaka Toshio²,Yano Wataru¹,Itou Takahiro¹,Yasumura Misako¹,Shimizu Yukari¹,Kobayashi Hideyuki¹,Nakagawa Takashi¹,Inoue Keisuke¹,Tanabe Sohei¹,Kondo Takuma²,Ishida Hitoshi²

Affiliation:

1. Tokyo New Drug Research Laboratories; Kowa Company, LTD.; Tokyo Japan

2. Third Department of Internal Medicine; Division of Diabetes, Endocrinology and Metabolism; Kyorin University School of Medicine; Tokyo Japan

Funder

Ministry of Education, Culture, Sports, Science and Technology

Publisher

Wiley

Subject

Physiology (medical),Physiology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.14814/phy2.13642/fullpdf

Reference35 articles.

1. Sodium-glucose cotransporter 2 inhibitor and a low carbohydrate diet affect gluconeogenesis and glycogen content differently in the kidney and the liver of non-diabetic mice;Atageldiyeva;PLoS ONE,2016

2. Adipose tissue dysfunction in obesity;Bluher;Exp. Clin. Endocrinol. Diabetes,2009

3. Dapagliflozin, a sodium-glucose co-transporter 2 inhibitor, acutely reduces energy expenditure in bat via neural signals in mice;Chiba;PLoS ONE,2016

4. Fatty liver is associated with transcriptional downregulation of stearoyl-CoA desaturase and impaired protein dimerization;Fernandez Gianotti;PLoS ONE,2013

5. Vascular effects of a low-carbohydrate high-protein diet;Foo;Proc. Natl. Acad. Sci. U S A,2009

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Canagliflozin protects the cardiovascular system through effects on the gut environment in non-diabetic nephrectomized rats;Clinical and Experimental Nephrology;2023-01-07

2. Selective PPARα Modulator Pemafibrate and Sodium-Glucose Cotransporter 2 Inhibitor Tofogliflozin Combination Treatment Improved Histopathology in Experimental Mice Model of Non-Alcoholic Steatohepatitis;Cells;2022-02-18

3. Biocomputational Prediction Approach Targeting FimH by Natural SGLT2 Inhibitors: A Possible Way to Overcome the Uropathogenic Effect of SGLT2 Inhibitor Drugs;Molecules;2021-01-22

4. Natural products with SGLT2 inhibitory activity: Possibilities of application for the treatment of diabetes;Phytotherapy Research;2019-07-29

5. Low Carbohydrate Diet and Diabetes Mellitus Treatment;Asploro Journal of Biomedical and Clinical Case Reports;2019-03-30